Related Experiment Videos
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity
International Journal of Immunopharmacology
|January 1, 1985
Summary
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) selectively harms immature B-cells in mouse bone marrow, impacting B-cell function. This immunotoxicity is dose-dependent and more pronounced in bone marrow than spleen B-cells.
Area of Science:
- Immunotoxicology
- Environmental Health
- Cell Biology
Background:
- The thymus, rich in immature T-cells, is known to be sensitive to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
- This sensitivity prompted an investigation into TCDD's effects on immature B-lymphocytes in the bone marrow.
Purpose of the Study:
- To determine if TCDD exhibits selective toxicity towards immature B-lymphocytes in the bone marrow.
- To evaluate the dose- and time-dependent effects of TCDD on B-cell function in mice.
Main Methods:
- Mice were administered varying doses of TCDD or saline over different time points.
- Assessed parameters included body weight, organ weights (thymus, spleen, bone marrow), and B-lymphocyte function using in vitro assays (colony forming unit and plaque forming cell assays).
Main Results:
- TCDD exposure significantly reduced thymus weight and B-cell function in both spleen and bone marrow in a dose-dependent manner.
- At the highest dose (120 µg/kg), thymic weight and bone marrow B-cell function were reduced to 6% and 18% of control, respectively, by day 21.
- Results indicated TCDD was more toxic to immature bone marrow B-cells than mature spleen B-cells.
Conclusions:
- TCDD demonstrates selective immunotoxicity towards immature B-lymphocytes in the bone marrow.
- The observed immunotoxicity is dose-dependent and highlights TCDD's potential to disrupt B-cell development and function.